‘I was not afraid to be different’: How founding a company at 49 helped Nykaa CEO Falguni Nayar become a multi-billionaire

The COVID pandemic pits competition against collaboration

The biopharma world has united around the COVID containment cause. But there’s still plenty of work ahead.

OpenAI says its making progress on “The Alignment Problem”

How to keep A. I. from running amok is a key concern as the technology gets more powerful. Read More

Party like it’s 1999—investors send these stocks into record territory

Europe’s benchmark, the Stoxx 600, is on one heck of a run. Read More